We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

C:NYSECitigroup, Inc. Analysis

Data as of 2026-03-09 - not real-time

$106.59

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Citi is trading at $106.6, comfortably above its 200‑day SMA of $100.1 but below the 20‑day ($113.2) and 50‑day ($115.8) averages, indicating a neutral to slightly bearish short‑term bias. The 14‑day RSI of 38.6 and a bearish MACD histogram reinforce this cautious stance, while volume is trending upward, suggesting buying interest may be building. On the valuation side, the trailing P/E of 15.2 sits below the industry average of 17.4 and the forward P/E of 8.8 signals significant earnings upside; the price‑to‑book of 0.97 also places the market price under the $110 book value per share. Dividend yield remains attractive at 2.25% with a modest 33% payout ratio, supporting cash‑flow sustainability.
Fundamentally, revenue growth of 4.4% and operating margins above 25% provide a solid earnings base, and analysts collectively rate the stock as a Buy with a mean price target of $134.8, implying roughly 26% upside. Recent analyst commentary, notably JPMorgan’s raise of the target to $134 and an Overweight rating, adds confidence to the upside thesis. However, the negative operating cash flow of $‑67.6 B and a sizable debt load of $777 B warrant monitoring, especially in a rising‑rate environment. The high beta (~1.3) and 30‑day volatility near 40% flag elevated market risk, but the diversified global footprint and strong capital position temper sector‑specific concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and RSI suggest limited upside in the near term
  • Increasing volume hints at potential buying pressure
  • Analyst target provides ~26% upside but price is near support

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Valuation discount (PE below industry, PB <1)
  • Forward earnings growth implied by low forward PE
  • Attractive dividend yield and sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified global banking franchise
  • Strong capital base and book value above price
  • Long‑term earnings stability and dividend growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth4.40%
Profit Margin18.89%
P/E Ratio15.2
ROE6.83%
ROA0.58%
P/B Ratio1.0
Op. Cash Flow$-67632001024
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI38.6
Support$102.01
Resistance$125.16
MA 20$113.18
MA 50$115.75
MA 200$100.08
MACDBearish
VolumeIncreasing
Fear & Greed Index100

Valuation

Target Price$134.77
Upside/Downside26.44%
GradeUndervalued
TypeBlend
Dividend Yield2.25%

Risk Assessment

Beta1.26
Volatility39.81%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.